Who Paid My Doc
Karen Gold
Urogynecology and Reconstructive Pelvic Surgery Tulsa, OK Medical Doctor
NPI 1518925692 CMS profile 250504
4444 E 41St St, 3Rd Floor Ste B, Tulsa, OK 74135
General payments
$1,319
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Karen Gold of Tulsa, OK is reported in the CMS Open Payments database as having received $1,319 across 16 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 27th percentile of Urogynecology and Reconstructive Pelvic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $48 | 1 | |
| 2023 | General | $38 | 2 | |
| 2022 | General | $42 | 3 | |
| 2019 | General | $1,191 | 10 |
Beside peers
- Karen Gold
- Urogynecology and Reconstructive Pelvic Surgery median
- Middle half of Urogynecology and Reconstructive Pelvic Surgery
- National median
In program year 2025, general payments to Karen Gold were reported at $0. Among 802 Urogynecology and Reconstructive Pelvic Surgery profiles paid that year, the median was $412 and the middle half received between $133 and $1,300.
Show as a table
| Year | Karen Gold | Urogynecology and Reconstructive Pelvic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,191 | $358 | $132–$1,270 | $163 |
| 2020 | $0 | $198 | $86–$642 | $114 |
| 2021 | $0 | $361 | $118–$1,182 | $132 |
| 2022 | $42 | $410 | $128–$1,175 | $149 |
| 2023 | $38 | $434 | $152–$1,344 | $160 |
| 2024 | $48 | $494 | $193–$1,331 | $164 |
| 2025 | $0 | $412 | $133–$1,300 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 23 billing codesPaid by Medicare
$5,532
Medicare patients
31
Services billed
69
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 68% | |
| Osteoporosis | 39% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
16 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Urogynecology and Reconstructive Pelvic Surgery in Oklahoma
Dena O Leary
Urogynecology and Reconstructive Pelvic Surgery · Edmond, OK
Benjamin Barenberg
Urogynecology and Reconstructive Pelvic Surgery · Oklahoma City, OK
Lieschen Quiroz
Urogynecology and Reconstructive Pelvic Surgery · Oklahoma City, OK
Adam Hare
Urogynecology and Reconstructive Pelvic Surgery · Oklahoma City, OK
Stephanie Pickett
Urogynecology and Reconstructive Pelvic Surgery · Edmond, OK
Gini Ikwuezunma
Urogynecology and Reconstructive Pelvic Surgery · Oklahoma City, OK
Related records
Urogynecology and Reconstructive Pelvic Surgery in Oklahoma
Practitioners in the same specialty and state, ranked by reported value.
All Urogynecology and Reconstructive Pelvic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Oklahoma
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.